West Pharmaceutical Services, Inc. logo

West Pharmaceutical Services, Inc. (WST)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
384. 02
+1
+0.2611%
$
26.96B Market Cap
49.01 P/E Ratio
0.88% Div Yield
511,200 Volume
7.62 Eps
$ 383.02
Previous Close
Add Transaction
Day Range
380.28 386.26
Year Range
223.83 386.26
Want to track WST and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

West Pharmaceutical Services, Inc. (WST) Statistics

Valuation metrics

Market Cap 26.96B
Enterprise value 26.9B
Trailing P/E (ttm) 48.8
Forward P/E 26.62
PEG ratio 2.85
Price/Sales (ttm) 8.12
Price/Book (mrq) 9.09
Enterprise Value/Revenue 8.09
Enterprise Value/EBITDA 30.91

Overview

Shares outstanding 72.04M
Float 71.52M
Shares short 2.37M
% Held by insiders 0.01%
% Held by institutions 0.98%
Average volume (10 days) 448.88K
Average volume (90 days) 612.88K

Price summary

52-Week low 223.83
52-Week high 386.26
Beta 1.18
50-Day moving average 361.45
200-Day moving average 332.77

Dividends and splits

Forward annual dividend rate 0.88
Forward annual dividend yield 0.0037%
Trailing annual dividend rate 0.88
Trailing annual dividend yield 0.0023%
5-Year annual dividend yield 0.25%
Payout ratio 0.11
Dividend Date 5 Aug 2026
Ex-Dividend Date 29 Jul 2026
Last split factor 2:1
Last split Date 27 Sep 2013

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin 0.17%
Operating margin 0.21%

Operational effectiveness

Return on assets 0.14%
Return on equity 0.19%

Income Statement

Revenue (ttm) 3.07B
Revenue per share (ttm) 46.98
Quarterly revenue growth (yoy) 0.07%
Gross profit (ttm) 1.1B
EBITDA 822.7M
Net income to common (ttm) 493.7M
Diluted EPS (ttm) 7.98
Quarterly earnings growth (yoy) 0.01%

Balance Sheet

Total cash (mrq) 791.3M
Total cash per share (mrq) 6.16
Total debt (mrq) 326.2M
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 2.82%
Book value per share (mrq) 42.23

Cash Flow

Cash flow statement 754.8M
Levered free cash flow (LFCF) 273.88M